The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era.

Abstract

Due to past success in testing and gaining regulatory approval for a variety of therapies in multiple sclerosis (MS), the conduct of future clinical trials has become increasingly problematic. An international workshop has met to discuss the issues facing the MS clinical trial community and to examine possible new strategies for the design of trials… (More)

Topics

Cite this paper

@article{Mcfarland2005TheFO, title={The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era.}, author={Henry F. Mcfarland and Stephen C. Reingold}, journal={Multiple sclerosis}, year={2005}, volume={11 6}, pages={669-76} }